Result: Respiratory syncytial virus–approved mAb Palivizumab as ligand for anti-idiotype nanobody-based synthetic cytokine receptors
Title:
Respiratory syncytial virus–approved mAb Palivizumab as ligand for anti-idiotype nanobody-based synthetic cytokine receptors / Julia Ettich, Christoph Wittich, Jens M. Moll, Kristina Behnke, Doreen M. Floss, Jens Reiners, Andreas Christmann, Philipp A. Lang, Sander H.J. Smits, Harald Kolmar, Jürgen Scheller
Involved:
Ettich, Julia (Verfasser) ; Wittich, Christoph (Verfasser) ; Moll, Jens M. (Verfasser) ; Behnke, Kristina (Verfasser) ; Floß, Doreen M. (Verfasser) ; Reiners, Jens (Verfasser) ; Christmann, Andreas (Verfasser) ; Lang, Philipp A. (Verfasser) ; Smits, Sander H. J. (Verfasser) ; Kolmar, Harald (Verfasser) ; Scheller, Jürgen (Verfasser)
Published in:
Journal of Biological Chemistry. - 2023. - 10.1016/j.jbc.2023.105270. - ISSN 1083-351X. - Jahrgang 299, Heft 11
Published:
Bethesda : Elsevier, 2023
Distribution:
Darmstadt : Universitäts- und Landesbibliothek Darmstadt
Scope:
1 Online-Ressource (18 Seiten)
Format:
Language:
English
DOI:
10.26083/tuprints-00027637
Open Access Rights:
Open Access
CC BY 4.0
CC BY 4.0